Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affected patients blister may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions, and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on the quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. This guideline for the treatment of bullous pemphigoid has been developed by an Italian group of experts taking in account the Italian legislation and local pharmacological governance. Guidelines are adapted from the original article under the guidance of the European Dermatology Forum (EDF) in collaboration with the European Academy of Dermatology and Venereology (EADV). It summarizes evidence-based and expert-based recommendations (S2 level).

Cozzani, E., Marzano, A.v., Caproni, M., Feliciani, C., Calzavara-Pinton, P., Alaibac, M., et al. (2018). Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 153(3), 305-315 [10.23736/S0392-0488.18.06006-6].

Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines

Talamonti Marina.;
2018-01-01

Abstract

Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affected patients blister may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions, and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on the quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. This guideline for the treatment of bullous pemphigoid has been developed by an Italian group of experts taking in account the Italian legislation and local pharmacological governance. Guidelines are adapted from the original article under the guidance of the European Dermatology Forum (EDF) in collaboration with the European Academy of Dermatology and Venereology (EADV). It summarizes evidence-based and expert-based recommendations (S2 level).
2018
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore MED/35 - MALATTIE CUTANEE E VENEREE
English
Con Impact Factor ISI
Bullous pemphigoid; Guideline; Rare diseases; Quality of life; Aged; Consensus; Evidence-Based Medicine; Humans; Italy; Pemphigoid, Bullous; Pruritus; Practice Guidelines as Topic; Quality of Life
Cozzani, E., Marzano, A.v., Caproni, M., Feliciani, C., Calzavara-Pinton, P., Alaibac, M., et al. (2018). Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 153(3), 305-315 [10.23736/S0392-0488.18.06006-6].
Cozzani, E; Marzano, Av; Caproni, M; Feliciani, C; Calzavara-Pinton, P; Alaibac, M; Antiga, E; Arisi, M; Assalve, D; Atzori, L; Babino, G; Balato, A; ...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
10.23736@S0392-0488.18.06006-6.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 578.06 kB
Formato Adobe PDF
578.06 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/244280
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 13
social impact